financetom
Business
financetom
/
Business
/
AutoZone's quarterly profit beats estimates on demand for car parts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AutoZone's quarterly profit beats estimates on demand for car parts
May 21, 2024 5:50 AM

(Reuters) - AutoZone ( AZO ) beat estimates for third-quarter profit on Tuesday, driven by strong demand for automotive parts as more Americans held on to their ageing cars amid higher prices and wait times for newer models.

Quarterly net sales at the auto parts supplier, which competes with Advance Auto Parts ( AAP ) and O'Reilly Automotive, rose 3.5% to about $4.24 billion.

Analysts on average were expecting AutoZone ( AZO ) to report third-quarter net sales of $4.29 billion.

On an adjusted basis, the company earned $36.69 per share in the quarter ended May 4, compared with analysts estimates of $35.96 per share, according to LSEG data.

However, domestic same-store sales in the quarter remained flat from a year earlier.

(Reporting by Nathan Gomes in Bengaluru; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sanofi wins US approval for drug combination to treat multiple myeloma
Sanofi wins US approval for drug combination to treat multiple myeloma
Sep 21, 2024
Sept 20 - Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed multiple myeloma, where it has previously been used only after standard treatments have failed, the U.S. Food and Drug Administration said on Friday. ...
Rev Group Insider Sold Shares Worth $356,250, According to a Recent SEC Filing
Rev Group Insider Sold Shares Worth $356,250, According to a Recent SEC Filing
Sep 21, 2024
04:09 PM EDT, 09/20/2024 (MT Newswires) -- Charles Dutil, Director, on September 18, 2024, sold 12,500 shares in Rev Group ( REVG ) for $356,250. Following the Form 4 filing with the SEC, Dutil has control over a total of 41,628 shares of the company, with 41,628 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1687221/000095010324013803/xslF345X05/dp218237_4.xml Price: 27.61, Change: -0.01, Percent Change: -0.04...
Longevity Biomedical to Go Public in SPAC deal with FutureTech II Acquisition
Longevity Biomedical to Go Public in SPAC deal with FutureTech II Acquisition
Sep 21, 2024
03:56 PM EDT, 09/20/2024 (MT Newswires) -- Blank-check firm FutureTech II Acquisition ( FTII ) agreed to a merger agreement earlier this week and take Longevity Biomedical public, the companies said Friday. The combined company will operate as Longevity Biomedical and is expected to list on Nasdaq under the LBIO ticker, the companies said. The new company will have approximately...
Rbc Bearings Insider Sold Shares Worth $837,202, According to a Recent SEC Filing
Rbc Bearings Insider Sold Shares Worth $837,202, According to a Recent SEC Filing
Sep 21, 2024
04:08 PM EDT, 09/20/2024 (MT Newswires) -- Edward Stewart, Director, on September 20, 2024, sold 2,800 shares in Rbc Bearings ( RBC ) for $837,202. Following the Form 4 filing with the SEC, Stewart has control over a total of 20,461 shares of the company, with 20,461 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1324948/000159396824001214/xslF345X05/primary_01.xml Price: 295.45, Change: +0.11, Percent Change: +0.04...
Copyright 2023-2026 - www.financetom.com All Rights Reserved